Showing 1 - 20 results of 36 for search 'N. Yu. Velts', query time: 0.03s
Refine Results
-
1
-
2
Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier by I. I. Snegireva, E. O. Zhuravleva, N. Yu. Velts
Published 2020-12-01
Article -
3
Nonsteroidal anti-inflammatory drugs: problems of safe use by N. Yu. Velts, E. O. Zhuravleva, T. M. Bukatina, G. V. Kutekhova
Published 2018-03-01
Article -
4
-
5
-
6
Rules of good laboratory practice: analysis of changes in the legislation by N. Yu. Velts, T. M. Bukatina, E. Yu. Pasternak, T. N. Nikolaeva, S. V. Romanova
Published 2018-02-01
Article -
7
The rules of good laboratory practice by N. Yu. Velts, R. N. Alyautdin, A. S. Kazakov, T. M. Bukatina, M. A. Darmostukova
Published 2018-02-01
Article -
8
Comparative Analysis of International Databases of Adverse Drug Reactions by A. S. Kazakov, M. A. Darmostukova, T. M. Bukatina, N. Yu. Velts, R. N. Alyautdin
Published 2020-09-01
Article -
9
Safety of apremilast: risk of psychical disorders by T. M. Bukatina, N. Yu. Velts, M. A. Darmostukova, E. Yu. Pasternak, T. V. Romanova
Published 2018-02-01
Article -
10
Malaria and safety issues associated with antimalarial drugs by A. S. Kazakov, T. M. Bukatina, N. Yu. Velts, M. A. Darmostukova, E. O. Zhuravleva
Published 2018-02-01
Article -
11
-
12
Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents by E. V. Shubnikova, T. M. Bukatina, N. Yu. Velts, D. A. Kaperko, G. V. Kutekhova
Published 2020-03-01
Article -
13
Vaccine Safety International Monitoring by M. A. Darmostukova, I. I. Snegireva, N. Yu. Velts, A. S. Kazakov, R. N. Alyautdin
Published 2019-03-01
Article -
14
Drug-induced liver injuries in pregnancy in the context of polypragmasy by N. Yu. Velts, E. O. Zhuravleva, M. A. Darmostukova, K. E. Zatolochina, O. S. Alyautdina
Published 2018-02-01
Article -
15
Drug Safety Monitoring Information by E. V. Shubnikova, E. O. Zhuravleva, N. Yu. Velts, P. M. Giulakhmedova, A. A. Druzhinina
Published 2021-07-01
Article -
16
SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE by E. O. Zhuravleva, N. Yu. Velts, G. V. Kutekhova, M. A. Darmostukova, R. N. Alyautdin
Published 2018-06-01
Article -
17
Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin by N. V. Molchan, Yu. A. Smirnova, N. Yu. Velts, M. A. Darmostukova, A. S. Kazakov, V. A. Polivanov
Published 2019-06-01
Article -
18
Safety of Antibacterial and Antiprotozoal Medicinal Products by E. V. Shubnikova, T. M. Bukatina, A. A. Druzhinina, E. O. Zhuravleva, G. V. Kutekhova, N. Yu. Velts
Published 2022-07-01
Article -
19
Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis by T. M. Bukatina, A. S. Kazakov, N. Yu. Velts, M. A. Darmostukova, E. Yu. Kolesnikova, R. N. Alyautdin, B. K. Romanov
Published 2018-02-01
Article -
20
On improving the safety of new direct acting oral anticoagulants by N. Yu. Velts, M. A. Darmostukova, A. S. Kazakov, T. M. Bukatina, O. E. Zhuravleva, R. N. Alyautdin, B. K. Romanov
Published 2018-02-01
Article